Praxis Precision Medicines Inc annual operating income for fiscal TTM was -$357 million, a decrease of 9.5% from -$326 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Operating Income (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | ($357M) | ($326M) | ($200M) | ($126M) | ($215M) | ($167M) | ($62M) | ($36M) | ($23M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Operating Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | ($97M) | ($106M) | ($97M) | ($78M) | ($76M) | ($75M) | ($64M) | ($57M) | ($37M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More PRAX metrics: Revenue · Gross Profit · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All PRAX financial statements → Interactive PRAX charts →
About TickerBase · Data methodology & sources · Privacy · Terms